All Updates

All Updates

icon
Filter
Product updates
QIAGEN discontinues NeuMoDx 96 and 288 Molecular Systems in effort refocus
Precision Medicine
Jun 6, 2024
This week:
Funding
GrayMatter Robotics raises USD 45 million in Series B funding to accelerate AI-powered robotics solutions
Smart Factory
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Logistics Tech
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Smart Factory
Yesterday
Funding
FairNow raises USD 3.5 million to advance AI governance solutions
Generative AI Infrastructure
Yesterday
Partnerships
Gravitics develops testing gauntlet for larger spacecraft in collaboration with NASA
Space Travel and Exploration Tech
Yesterday
M&A
knownwell acquires Alfie Health to integrate AI in primary and obesity care services
Telehealth
Yesterday
Funding
Pomelo Care raises USD 46 million in Series B funding to expand virtual maternal care
Telehealth
Yesterday
Funding
Isar Aerospace raises EUR 65 million, backed by NATO Innovation Fund
Space Travel and Exploration Tech
Yesterday
Product updates
Beyond Meat releases new Beyond Sausage, expanding its Beyond IV product line
Plant-based Meat
Yesterday
Product updates
Funding
SurrealDB raises USD 20 million in Series A; launches beta version of Surreal Cloud
Data Infrastructure & Analytics
Yesterday
Precision Medicine

Precision Medicine

Jun 6, 2024

QIAGEN discontinues NeuMoDx 96 and 288 Molecular Systems in effort refocus

Product updates

  • QIAGEN has announced the discontinuation of the NeuMoDx 96 and 288 Molecular Systems in response to changing trends and demand for integrated PCR-based clinical molecular testing systems.

  • The company intends to focus on the QIAstat-Dx system for syndromic testing, the QIAcuity portfolio of digital PCR systems, and the QIAGEN Digital Insights (QDI) bioinformatics business.

  • QIAGEN also plans to build its leadership position in Sample technologies and the QuantiFERON-TB franchise. The company claims that it will provide the necessary support for existing NeuMoDx users during the transition, including maintenance, technical support, and the provision of necessary consumables, until 2025.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.